These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 2104438

  • 1. [Subcutaneous injections and intravenous infusion of sodium salt of heparin in the treatment of thrombosis of deep veins of the lower extremities].
    Lopaciuk S, Misiak A, Wisławski S, Ciesielski L, Korzycki J, Judkiewicz L, Lewandowski K, Tokarz A, Kłoczko J, Bielawiec M.
    Pol Tyg Lek; ; 45(47-48):949-52. PubMed ID: 2104438
    [Abstract] [Full Text] [Related]

  • 2. Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis--a randomized clinical trial.
    Pini M, Pattachini C, Quintavalla R, Poli T, Megha A, Tagliaferri A, Manotti C, Dettori AG.
    Thromb Haemost; 1990 Oct 22; 64(2):222-6. PubMed ID: 2270531
    [Abstract] [Full Text] [Related]

  • 3. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
    Simonneau G, Charbonnier B, Decousus H, Planchon B, Ninet J, Sie P, Silsiguen M, Combe S.
    Arch Intern Med; 1993 Jul 12; 153(13):1541-6. PubMed ID: 8391792
    [Abstract] [Full Text] [Related]

  • 4. Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial.
    Lopaciuk S, Meissner AJ, Filipecki S, Zawilska K, Sowier J, Ciesielski L, Bielawiec M, Glowinski S, Czestochowska E.
    Thromb Haemost; 1992 Jul 06; 68(1):14-8. PubMed ID: 1325076
    [Abstract] [Full Text] [Related]

  • 5. [Continuous intravenous infusion versus intermittent administration of streptokinase in patients with deep venous thrombosis of the lower extremity].
    Lopaciuk S, Meissner AJ, Ziemski JM, Tokarz A, Psuja P, Zawilska K, Głowiński S, Wołczyński Z, Czestochowska E, Tymiński W.
    Pol Tyg Lek; 1992 Jul 06; 46(37-39):704-7. PubMed ID: 1669137
    [Abstract] [Full Text] [Related]

  • 6. [Heparin treatment. Comparison between intravenous and subcutaneous administration].
    Krähenbühl B, Simon CA, Bouvier CA, Schinas P, Hopf MA, Cochet B.
    Schweiz Med Wochenschr; 1979 Sep 22; 109(36):1322-5. PubMed ID: 504973
    [Abstract] [Full Text] [Related]

  • 7. Treatment of deep vein thrombosis with continuous intravenous infusion of LMWH in children--an alternative to subcutaneous application when needed.
    Blatný J, Fiamoli V.
    Vnitr Lek; 2009 Mar 22; 55(3):227-32. PubMed ID: 19378852
    [Abstract] [Full Text] [Related]

  • 8. An exploratory trial of two dosages of a novel synthetic thrombin inhibitor (napsagatran, Ro 46-6240) compared with unfractionated heparin for treatment of proximal deep-vein thrombosis -- results of the European multicenter ADVENT trial.
    Bounameaux H, Ehringer H, Hulting J, Rasche H, Rapold HJ, Zultak M.
    Thromb Haemost; 1997 Sep 22; 78(3):997-1002. PubMed ID: 9308743
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Subcutaneous recombinant hirudin (HBW 023) versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective dose-ranging randomized trial. International Multicentre Hirudin Study Group.
    Schiele F, Lindgaerde F, Eriksson H, Bassand JP, Wallmark A, Hansson PO, Grollier G, Sjo M, Moia M, Camez A, Smyth V, Walker M.
    Thromb Haemost; 1997 May 22; 77(5):834-8. PubMed ID: 9184388
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Therapy of thrombosis with conventional heparin].
    Harenberg J.
    Z Kardiol; 1993 May 22; 82 Suppl 2():71-5. PubMed ID: 8328212
    [Abstract] [Full Text] [Related]

  • 14. Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group.
    Charbonnier BA, Fiessinger JN, Banga JD, Wenzel E, d'Azemar P, Sagnard L.
    Thromb Haemost; 1998 May 22; 79(5):897-901. PubMed ID: 9609216
    [Abstract] [Full Text] [Related]

  • 15. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
    Ramacciotti E, Araújo GR, Lastoria S, Maffei FH, Karaoglan de Moura L, Michaelis W, Sandri JL, Dietrich-Neto F, CLETRAT Investigators.
    Thromb Res; 2004 May 22; 114(3):149-53. PubMed ID: 15342210
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosis.
    Stricker H, Marchetti O, Haeberli A, Mombelli G.
    Thromb Haemost; 1999 Oct 22; 82(4):1227-31. PubMed ID: 10544903
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.